08:53 AM EDT, 10/03/2024 (MT Newswires) -- Health care stocks were steady premarket Thursday with the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) recently inactive.

Hims & Hers Health ( HIMS ) shares declined 11% after the US Food and Drug Administration said that a shortage of tirzepatide injection medication has been resolved. Hims & Hers and other generic drug makers are allowed to sell versions of FDA-approved drugs when they are in shortage.